ZAI LAB LIMITED Finite-Lived Intangible Assets, Net
ZAI LAB LIMITED (ZLAB) had Finite-Lived Intangible Assets, Net of $85.77 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2026-08-06
- 2026-06-30: Finite-Lived Intangible Assets, Net $85.77M.
- 2026-03-31: Finite-Lived Intangible Assets, Net $75.76M.
- 2025-12-31: Finite-Lived Intangible Assets, Net $76.14M.
- 2025-09-30: Finite-Lived Intangible Assets, Net $55.28M.
| Period end | Finite-Lived Intangible Assets, Net |
|---|---|
| 2026-06-30 | $85.77M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $75.76M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $76.14M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $55.28M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $56.52M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $56.20M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $56.03M 10-K · filed 2026-02-26 |
| 2024-09-30 | $51.67M 10-Q · filed 2024-11-12 |
| 2023-12-31 | $13.39M 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |